- Home
- SIDU vs RNXT Comparison
SIDU vs RNXT Comparison
Compare SIDU & RNXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SIDU
- RNXT
- Stock Information
- Founded
- SIDU 2012
- RNXT 2012
- Country
- SIDU United States
- RNXT United States
- Employees
- SIDU 82
- RNXT N/A
- Industry
- SIDU Telecommunications Equipment
- RNXT Biotechnology: Pharmaceutical Preparations
- Sector
- SIDU Telecommunications
- RNXT Health Care
- Exchange
- SIDU Nasdaq
- RNXT Nasdaq
- Market Cap
- SIDU 34.5M
- RNXT 31.6M
- IPO Year
- SIDU 2021
- RNXT 2021
- Fundamental
- Price
- SIDU $2.40
- RNXT $1.03
- Analyst Decision
- SIDU Strong Buy
- RNXT Strong Buy
- Analyst Count
- SIDU 1
- RNXT 1
- Target Price
- SIDU $10.00
- RNXT $9.00
- AVG Volume (30 Days)
- SIDU 1.1M
- RNXT 214.8K
- Earning Date
- SIDU 03-25-2025
- RNXT 03-31-2025
- Dividend Yield
- SIDU N/A
- RNXT N/A
- EPS Growth
- SIDU N/A
- RNXT N/A
- EPS
- SIDU N/A
- RNXT N/A
- Revenue
- SIDU $5,189,912.00
- RNXT N/A
- Revenue This Year
- SIDU $36.85
- RNXT N/A
- Revenue Next Year
- SIDU $40.00
- RNXT N/A
- P/E Ratio
- SIDU N/A
- RNXT N/A
- Revenue Growth
- SIDU N/A
- RNXT N/A
- 52 Week Low
- SIDU $1.15
- RNXT $0.77
- 52 Week High
- SIDU $10.15
- RNXT $1.86
- Technical
- Relative Strength Index (RSI)
- SIDU 42.76
- RNXT 35.37
- Support Level
- SIDU $2.56
- RNXT $1.00
- Resistance Level
- SIDU $2.75
- RNXT $1.18
- Average True Range (ATR)
- SIDU 0.22
- RNXT 0.10
- MACD
- SIDU -0.00
- RNXT -0.03
- Stochastic Oscillator
- SIDU 22.08
- RNXT 6.00
About SIDU Sidus Space Inc.
Sidus Space Inc is a Space and Defense as-a-Service company focused on providing complex space hardware, satellite/spacecraft design, manufacture, launch, and data solutions for both government and commercial in-space missions for all destinations through the solar system. This includes a Space-based infrastructure of multi-mission satellites with hyperspectral, multi-spectral, and other sensors to provide monitoring services and solutions to multiple sectors and industries. The company supports Commercial Space, Aerospace, Defense, Underwater Marine, and other commercial and government customers.
About RNXT RenovoRx Inc.
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.